BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17659933)

  • 1. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
    Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
    Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA
    Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.
    Grassi G; Seravalle G; Bertinieri G; Turri C; Stella ML; Scopelliti F; Mancia G
    Clin Sci (Lond); 2001 Aug; 101(2):141-6. PubMed ID: 11473487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma myeloperoxidase levels in patients with chronic heart failure.
    Tang WH; Brennan ML; Philip K; Tong W; Mann S; Van Lente F; Hazen SL
    Am J Cardiol; 2006 Sep; 98(6):796-9. PubMed ID: 16950188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure.
    Satoh S; Oyama J; Suematsu N; Kadokami T; Shimoyama N; Okutsu M; Inoue T; Sugano M; Makino N
    Int J Cardiol; 2006 Aug; 111(3):405-12. PubMed ID: 16271779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Choi BR; Kim JS; Yang YJ; Park KM; Lee CW; Kim YH; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
    Am J Cardiol; 2006 May; 97(9):1365-9. PubMed ID: 16635612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
    Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy.
    Pascual-Figal DA; Peñafiel P; de la Morena G; Redondo B; Nicolás F; Casas T; Valdés M
    Am J Cardiol; 2007 May; 99(9):1279-83. PubMed ID: 17478157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parsonage WA; Galbraith AJ; Koerbin GL; Potter JM
    Am J Cardiol; 2005 Apr; 95(7):883-5. PubMed ID: 15781024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.
    Gürgün C; Ildizli M; Yavuzgil O; Sin A; Apaydin A; Cinar C; Kültürsay H
    Int J Cardiol; 2008 Jan; 123(2):102-7. PubMed ID: 17320212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered chemokine receptor profile on circulating leukocytes in human heart failure.
    Athanassopoulos P; Vaessen LM; Balk AH; Weimar W; Sharma HS; Bogers AJ
    Cell Biochem Biophys; 2006; 44(1):83-101. PubMed ID: 16456237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy.
    Ware WA; Lund DD; Subieta AR; Schmid PG
    J Am Vet Med Assoc; 1990 Dec; 197(11):1475-81. PubMed ID: 2272879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy.
    Athanassopoulos P; Balk AH; Vaessen LM; Caliskan K; Takkenberg JJ; Weimar W; Bogers AJ
    Int J Cardiol; 2009 Jan; 131(2):246-56. PubMed ID: 18243370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
    Smilde TD; Hillege HL; Navis G; Boomsma F; de Zeeuw D; van Veldhuisen DJ
    Am Heart J; 2004 Jul; 148(1):165-72. PubMed ID: 15215807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.